Results 201 to 210 of about 278,857 (261)

Deep learning enabled pseudonymization for preserving data privacy of financial identifiers in public documents in India. [PDF]

Sci Rep
Roopalakshmi R, Kailas S, Sreelatha R.
europepmc   +1 more source

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi, Caroline Gochanour, Seung Ho Choi, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher Coffey, Michael Brumm, David‐Erick Lafontant, Yuge Xiao, Thomas Tropea, John Seibyl, Caroline Tanner, Charles S. Venuto, Karl Kieburtz, Lana M. Chahine, Kathleen L. Poston, Andrew Siderowf, Kenneth Marek, Tanya Simuni, The Parkinson's Progression Markers Initiative   +19 more
wiley   +1 more source

Varying Influence of Menstrual Cycle Phase and Hormonal Contraceptive Use on Resistance Exercise-Induced Circulating Extracellular Vesicle and Metabolite Signalling. [PDF]

J Extracell Vesicles
Kargl CK, Nindl BC, Goulart JB, Feigel ED, Sahu A, Fazeli PK, Lee AL, Rajasundaram D, Ambrosio F, Hubal MJ, Lovalekar MT, Martin BJ, Sterczala AJ, Koltun KJ.   +13 more
europepmc   +1 more source

Subtype-Specific mRNA Signatures of Human Ribosomal Proteins in Pediatric Cancers. [PDF]

Int J Mol Sci
Panda A, Yadav A, Bhanot G, Ganesan S.
europepmc   +1 more source

Modern wITCHcraft: Conjuring pruritus-associated gene signatures through microarray profiling. [PDF]

J Eur Acad Dermatol Venereol
Mueller SM.
europepmc   +1 more source

Gut fungal signatures predict disease status in acute ischemic stroke. [PDF]

iScience
Yan Q, Pu L, Yuan S, Zhang Z, Lv W, Yuan W, Liu J, Jiang L, Wang S, Zhang D.   +9 more
europepmc   +1 more source

A comprehensive analysis of the correlation between plasma cytokines/chemokines and tumor immune microenvironment signature influences the response of checkpoint inhibitors in advanced non-small-cell lung cancer. [PDF]

Clin Transl Immunology
Mai VH, Prasanpanich M, Zungsontiporn N, Korphaisarn K, Sitthideatphaiboon P, Aporntewan C, Chantranuwat P, Hirankarn N, Vinayanuwattikun C.   +8 more
europepmc   +1 more source